Guest guest Posted December 3, 2010 Report Share Posted December 3, 2010 According to the authors, this represents the first clinical trial examining the potential synergy between a tyrosine kinase inhibitor and a conventional alkylating agent for the treatment of CLL. This is a tiny Phase I trial for previously treated CLL patients The combination of chlorambucil and imatinib in patients with previously treated CLL was well tolerated and showed evidence of clinical efficacy. Cancer Chemother Pharmacol. 2010 Dec 1 Link: to Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21120481?dopt=Abstract ~chris CLL CANADA Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.